Concepedia

Author

Rosemary Schroyer

GlaxoSmithKline (United States)

Also Known As

R. Schroyer, Rosemary O Schroyer, Rosemary O. Schroyer, Rosemary Schroyer

7

Publications

312

Citations

5

H-Index

0

Concepts

All Affiliations

GlaxoSmithKline (United States)GlaxoSmithKline (United Kingdom)Addenbrooke's Hospital
RS

About

Rosemary Schroyer is an author at GlaxoSmithKline (United States).

Rosemary Schroyer

×

3

Publications

186

Citations

3

H-Index

YearCitations

Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects

Navin Goyal, Peter J. Skrdla, Rosemary Schroyer,

American Journal of Cardiovascular Drugs

2019

139

A pilot study evaluating GSK1070806 inhibition of interleukin-18 in renal transplant delayed graft function

Elizabeth Wlodek, Robert B. Kirkpatrick, Susan Andrews,

PLoS ONE

2021

25

Long-term up to 24-month efficacy and safety of concomitant prescription omega-3-acid ethyl esters and simvastatin in hypertriglyceridemic patients

Harold Bays, Kevin C. Maki, James M. McKenney,

Current Medical Research and Opinion

2010

22

Page 1